Old Lyme, CT, United States of America

Kevin Barry Bahnck

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Barry Bahnck. Retrieved from https://idiyas.com/inventor/kevin-barry-bahnck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Old Lyme, CT (US) (2016)
  • Bridport, VT (US) (2017)

Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin Barry Bahnck: Innovator in Prostaglandin Research

Introduction

Kevin Barry Bahnck is a notable inventor based in Old Lyme, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of antagonists for the prostaglandin EP3 receptor. With a total of 2 patents to his name, Bahnck's work is pivotal in advancing therapeutic options for various medical conditions.

Latest Patents

Bahnck's latest patents focus on antagonists of the prostaglandin EP3 receptor. These patents detail processes for creating these antagonists and methods for administering them to mammals in need. His innovative approach aims to provide new avenues for treatment in areas where prostaglandin signaling plays a critical role.

Career Highlights

Kevin Barry Bahnck is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Bahnck has had the opportunity to work alongside esteemed colleagues such as David James Edmonds and Kentaro Futatsugi. These collaborations enhance the research environment and foster innovation within the team.

Conclusion

Kevin Barry Bahnck's contributions to the field of pharmacology through his patents on prostaglandin EP3 receptor antagonists highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…